XML 16 R5.htm IDEA: XBRL DOCUMENT v3.22.1
Statements of Changes in Stockholders' Equity - USD ($)
$ in Thousands
Preferred Stock
Series A Convertible Preferred Stock
Preferred Stock
Series A and B Convertible Preferred Stock
Preferred Stock
Common stock
At-the-market sales
Common stock
Series A Convertible Preferred Stock
Common stock
Additional Paid in Capital.
At-the-market sales
Additional Paid in Capital.
Series A Convertible Preferred Stock
Additional Paid in Capital.
Accumulated Other Comprehensive Income
Accumulated Deficit
At-the-market sales
Series A and B Convertible Preferred Stock
Total
Balance at Dec. 31, 2020                 $ 361,548 $ 3 $ (312,223)     $ 49,328
Balance (in shares) at Dec. 31, 2020           2,189,094                
Increase (decrease) in stockholders' equity                            
Share-based compensation - stock options and RSUs                 742         742
Issuance of common stock             $ 960         $ 960    
Issuance of common stock (in shares)       13,023                    
Issuance of common stock upon exercise of options                 75         75
Issuance of common stock upon exercise of options (in shares)           3,160                
Vesting of RSUs (in shares)           1,316                
Warrants issued in connection with long-term debt                 1,080         1,080
Unrealized net gain on marketable securities                   $ (3)       (3)
Net loss                     (17,128)     (17,128)
Balance at Mar. 31, 2021                 364,405   (329,351)     35,054
Balance (in shares) at Mar. 31, 2021           2,206,593                
Balance at Dec. 31, 2021                 396,388   (387,117)     9,271
Balance (in shares) at Dec. 31, 2021           3,034,901                
Increase (decrease) in stockholders' equity                            
Share-based compensation - stock options and RSUs                 764         764
Issuance of common stock             $ 348         $ 348    
Issuance of common stock (in shares)       25,623                    
Registered direct financing costs, inclusive of warrants     $ (965)           244         (721)
Conversion of convertible preferred stock $ (897) $ 4,850           $ 897         $ 4,850  
Conversion of convertible preferred stock (in shares) (2,425) 4,850     303,125                  
Vesting of RSUs (in shares)           1,773                
Warrants issued in connection with registered direct offering     (2,101)           2,101          
Net loss                     (11,769)     (11,769)
Balance at Mar. 31, 2022     $ 887           $ 400,742   $ (398,886)     $ 2,743
Balance (in shares) at Mar. 31, 2022     2,425     3,365,422